Anti-inflammatory drugs, antioxidants, and prostate cancer prevention
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 9 (4) , 419-426
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Association of IL10 and Other immune response‐ and obesity‐related genes with prostate cancer in CLUE IIThe Prostate, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Vitamins E and C in the Prevention of Prostate and Total Cancer in MenJAMA, 2009
- Statin use and prostate cancer risk in a large population-based settingCancer Causes & Control, 2008
- Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II studyBritish Journal of Cancer, 2007
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumorsProceedings of the National Academy of Sciences, 2007
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005
- The SU.VI.MAX StudyArchives of internal medicine (1960), 2004